PANCURONIUM BROMIDE Drug Patent Profile
✉ Email this page to a colleague
When do Pancuronium Bromide patents expire, and what generic alternatives are available?
Pancuronium Bromide is a drug marketed by Dr Reddys, Elkins Sinn, Hospira, and Igi Labs Inc. and is included in eleven NDAs.
The generic ingredient in PANCURONIUM BROMIDE is pancuronium bromide. There are six drug master file entries for this compound. Additional details are available on the pancuronium bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pancuronium Bromide
A generic version of PANCURONIUM BROMIDE was approved as pancuronium bromide by HOSPIRA on January 19th, 1989.
Summary for PANCURONIUM BROMIDE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 59 |
Patent Applications: | 2,642 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PANCURONIUM BROMIDE at DailyMed |